Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Alkindo Naratama Tbk (ALDO) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Alkindo Naratama TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Alkindo Naratama Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Alkindo Naratama Tbk trades at Rp850 (market cap 2.35T, 43.7K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp167 (market cap 651.75B, 626.9K 24h volume). The key difference: Alkindo Naratama Tbk is far larger — about 3.6× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (626.9K versus 43.7K). Which is the better fit depends on your goals.

ALDOLABS
Market Cap
2.35T651.75B
Volume
43.7K626.9K
Lot
4376.27K
Turnover
36.82M103.6M
Average Price
842.6165.25
Value
36.82M103.6M
Indicative Equilibrium Price
835165
Indicative Equilibrium Volume
8300

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ALDO
View details
LABS
View details

About Alkindo Naratama Tbk

PT Alkindo Naratama Tbk (the "Company") was established based on Notarial Deed No 74 of Kikit Warianti SH, dated January 31, 1989. The Company's Articles of Association have been amended several times. The latest amendment was based on Notarial Deed No. 5 of Nunuy Rahmayati SH dated March 15, 2011 pertaining of Authorized share and paid-up capital, issuance of new share to be offered to the public in the Initial Public Offering, and amendment of the Article of Association of the Company to become a public entity

Read more on ALDO

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS